High-tech therapies such as gene, cell, and orphan drug therapies are becoming more popular, and that these therapies can be very costly.

Self-insured employers are seeing an increase in high-cost health claims in the area of respiratory illness and mental health, a new report has found. The 2021 Accident and Health Market Report, released by stop-loss insurer QBE compared high-dollar claims from the months preceding the COVID-19 pandemic to costs from the early months of 2021. It found that while the top area of high-dollar claims, cancer treatment, moderated somewhat, other high-cost claims in the areas of respiratory illness and mental health saw significant increases.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.